Effectiveness and Utility of Telemonitoring in Improving the Glycaemic Control of Diabetes Mellitus Tunisian Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Monastir
About this trial
The study aims to evaluate the impact of a telemonitoring system on glycemic control in patients with diabetes in Tunisia. Participants in the intervention group will receive remote diabetes management through a dedicated mobile application and web platform, while the control group will receive standard diabetes care. The primary objective is to determine the effectiveness of telemonitoring in improving glycemic control, as assessed by changes in glycated hemoglobin (HbA1c) and blood glucose levels.
Eligibility criteria
Qualifiers
Diagnosis of diabetes mellitus with HbA1c between 7% and 10%.
Stable antidiabetic treatment for at least 4 weeks prior to enrollment.
Disqualifiers
Serum creatinine >200 µmol/L.
Acute coronary syndrome or stroke.
Dementia.
Pregnancy.
Trial design
Treatments tested in this trial
- Telemonitoring group
- Usual Care Group
Treatment groups
260 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov